The epigenetic life cycle of epstein–barr virus

Current Topics in Microbiology and Immunology

Volumn 390, Issue , 2015, Pages 103-117

  Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; HISTONE METHYLTRANSFERASE; IMMEDIATE EARLY PROTEIN BZLF1; LONG UNTRANSLATED RNA; MICRORNA; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BCL 2; RNA POLYMERASE II; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR EZH2;

B LYMPHOCYTE; BURKITT LYMPHOMA CELL LINE; CPG ISLAND; DNA METHYLATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE CONTROL; GENE SILENCING; HERPES SIMPLEX VIRUS; HISTONE MODIFICATION; HUMAN; LIFE CYCLE STAGE; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS GENOME; VIRUS LATENCY; ANIMAL; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; VIRUS REPLICATION;

EID: 84942847381     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-22822-8_6     Document Type: Chapter

References (65)

1. Alfieri C, Birkenbach M, Kieff E (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595–608
2. Altmann M, Hammerschmidt W (2005) Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3:e404
3. Amon W, Binne UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ (2004) Lytic cycle gene regulation of Epstein-Barr virus. J Virol 78:13460–13469
4. Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, Leslie C, Lieberman PM (2012) An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12:233–245
5. Aubry V, Mure F, Mariame B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H (2014) Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J Virol 88:12825–12838
6. Bechtel J, Grundhoff A, Ganem D (2005) RNAs in the virion of Kaposi’s sarcoma-associated herpesvirus. J Virol 79:10138–10146
7. Bergbauer M, Kalla M, Schmeinck A, Gobel C, Rothbauer U, Eck S, Benet-Pages A, Strom TM, Hammerschmidt W (2010) CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog 6:e1001114
8. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2004) The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36:1099–1104
9. Bresnahan WA, Shenk T (2000) A subset of viral transcripts packaged within human cytomegalovirus particles. Science 288:2373–2376
10. Chiu YF, Sugden AU, Sugden B (2013) Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition. Cell Host Microbe 14:607–618
11. Cliffe AR, Nash AA, Dutia BM (2009) Selective uptake of small RNA molecules in the virion of murine gammaherpesvirus 68. J Virol 83:2321–2326
12. Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82:4085–4089
13. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC (2009) Methylationdependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog 5:e1000356
14. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J 8:127–132
15. Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080–3089
16. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19:438–451
17. Fixman ED, Hayward GS, Hayward SD (1992) Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol 66:5030–5039
18. Gibson W, Roizman B (1971) Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Natl Acad Sci U S A 68:2818–2821
19. Greijer AE, Dekkers CA, Middeldorp JM (2000) Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J Virol 74:9078–9082
20. Gruffat H, Kadjouf F, Mariame B, Manet E (2012) The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J Virol 86:6023–6032
21. Gunther T, Grundhoff A (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6:e1000935
22. Gustems M, Woellmer A, Rothbauer U, Eck SH, Wieland T, Lutter D, Hammerschmidt W (2014) c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs. Nucleic Acids Res 42:3059–3072
23. Holdorf MM, Cooper SB, Yamamoto KR, Miranda JJ (2011) Occupancy of chromatin organizers in the Epstein-Barr virus genome. Virology 415:1–5
24. Hurley EA, Thorley-Lawson DA (1988) B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med 168:2059–2075
25. Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R (2012a) The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8:e1002704
26. Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R (2012b) RNAs in Epstein-Barr virions control early steps of infection. Proc Natl Acad Sci USA 109:E1396–E1404
27. Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E (2004) Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA 101:16286–16291
28. Kalamvoki M, Du T, Roizman B (2014) Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci USA 111:E4991–E4996
29. Kalla M, Gobel C, Hammerschmidt W (2012) The lytic phase of Epstein-Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. J Virol 86:447–458
30. Kalla M, Hammerschmidt W (2012) Human B cells on their route to latent infection–early but transient expression of lytic genes of Epstein-Barr virus. Eur J Cell Biol 91:65–69
31. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W (2010) AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci USA 107:850–855
32. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ (2008) Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog 4:e1000005
33. Kenney SC, Mertz JE (2014) Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol 26:60–68
34. Kintner C, Sugden B (1981) Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J Virol 38:305–316
35. Lieberman PM (2013) Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 11:863–875
36. Meilinger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, Klinkert WE, Spada F, Leonhardt H (2009) Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO Rep 10:1259–1264
37. Minarovits J (2006) Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 310:61–80
38. Murata T, Tsurumi T (2014) Switching of EBV cycles between latent and lytic states. Rev Med Virol 24:142–153
39. Paulson EJ, Speck SH (1999) Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol 73:9959–9968
40. Petosa C, Morand P, Baudin F, Moulin M, Artero JB, Muller CW (2006) Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21:565–572
41. Ramasubramanyan S, Osborn K, Flower K, Sinclair AJ (2012) Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome. J Virol 86:1809–1819
42. Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE (2015) Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters. J Virol 89:1731–1743
43. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H (2010) The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res 38:1796–1804
44. Schaefer BC, Strominger JL, Speck SH (1995) Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci USA 92:10565–10569
45. Schlager S, Speck SH, Woisetschlager M (1996) Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. J Virol 70:3561–3570
46. Schmeinck A (2011) Acquisition and loss of chromatin modifications during an Epstein-Barr Virus infection. Munich: Ludwig Maximilians-University, 1 p. Dissertation
47. Sciortino MT, Suzuki M, Taddeo B, Roizman B (2001) RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol 75:8105–8116
48. Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse HJ (2005) Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J Gen Virol 86:3009–3019
49. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ (2006) Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103:7065–7070
50. Sinclair AJ (2003) ZIP proteins of human gammaherpesviruses. J Gen Virol 84:1941–1949
51. Takada K, Shimizu N, Sakuma S, Ono Y (1986) Transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57:1016–1022
52. Taylor N, Flemington E, Kolman JL, Baumann RP, Speck SH, Miller G (1991) ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein- Barr virus BZLF1 promoter. J Virol 65:4033–4041
53. Tempera I, Klichinsky M, Lieberman PM (2011) EBV latency types adopt alternative chromatin conformations. PLoS Pathog 7:e1002180
54. Tempera I, Wiedmer A, Dheekollu J, Lieberman PM (2010) CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog 6:e1001048
55. Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A (2007) Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program. J Virol 81:10092–10100
56. Tierney RJ, Kirby HE, Nagra JK, Desmond J, Bell AI, Rickinson AB (2000) Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J Virol 74:10468–10479
57. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6:e1001013
58. Tsai CL, Li HP, Lu YJ, Hsueh C, Liang Y, Chen CL, Tsao SW, Tse KP, Yu JS, Chang YS (2006) Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 66:11668–11676
59. Tsai K, Chan L, Gibeault R, Conn K, Dheekollu J, Domsic J, Marmorstein R, Schang LM, Lieberman PM (2014) Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. J Virol 88:14350–14363
60. Walling DM, Flaitz CM, Nichols CM, Hudnall SD, Adler-Storthz K (2001) Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J Infect Dis 184:1499–1507
61. Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K (2007) Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol 81:1037–1042
62. Woellmer A, Arteaga-Salas JM, Hammerschmidt W (2012) BZLF1 governs CpG-methylated chromatin of Epstein-Barr virus reversing epigenetic repression. PLoS Pathog 8:e1002902
63. Woellmer A, Hammerschmidt W (2013) Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation. Curr Opin Virol 3:260–265
64. Woisetschlaeger M, Yandava CN, Furmanski LA, Strominger JL, Speck SH (1990) Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci USA 87:1725–1729
65. Zhou J, Chau CM, Deng Z, Shiekhattar R, Spindler MP, Schepers A, Lieberman PM (2005) Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J 24:1406–1417